Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07186556 · ClinicalTrials.gov registry record · NA

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

A NA study of Cancer and Fatigue, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT07186556 is a NA study of Cancer and Fatigue that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 75 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07186556, a NA study of Cancer and Fatigue, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer survivors.

Interventions

  • BEHAVIORAL RISE-YA Intervention
  • BEHAVIORAL Survivorship Education

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-09-09
Est. Completion 2031-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07186556

The ClinicalTrials.gov registry entry for NCT07186556 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which RISE-YA Intervention is the first listed.

NCT07186556 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07186556 about?

NCT07186556 is a clinical study titled "Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention". The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer survivors.

What is the current status of trial NCT07186556?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-09-09. Estimated completion is 2031-12-31.

What conditions does trial NCT07186556 study?

This clinical trial studies the following conditions: Cancer, Fatigue, Brain Tumor Adult.

What interventions are being tested in trial NCT07186556?

The interventions under investigation include: RISE-YA Intervention (BEHAVIORAL), Survivorship Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07186556?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07186556 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.